Basilea News http://www.basilea.com/ Basilea News en Thu, 17 May 2012 13:47:09 +0200 Thu, 17 May 2012 13:47:09 +0200 Chameleon CMS webmaster@basila.com (Webmaster Webmaster) webmaster@basila.com (Webmaster Webmaster) <![CDATA[Ordinary General Meeting of Shareholders of Basilea Pharmaceutica Ltd.]]> http://www.basilea.com/News-and-Media/Ordinary-General-Meeting-of-Shareholders-of-Basilea-Pharmaceutica-Ltd-/432 Tue, 17 Apr 2012 19:48:22 +0200 http://www.basilea.com/News-and-Media/Ordinary-General-Meeting-of-Shareholders-of-Basilea-Pharmaceutica-Ltd-/432 <![CDATA[Basilea presents new research data on a biomarker for its novel oncology drug candidate BAL101553 at AACR]]> http://www.basilea.com/News-and-Media/Basilea-presents-new-research-data-on-a-biomarker-for-its-novel-oncology-drug-candidate-BAL101553-at-AACR/429 Wed, 04 Apr 2012 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-presents-new-research-data-on-a-biomarker-for-its-novel-oncology-drug-candidate-BAL101553-at-AACR/429 <![CDATA[Basilea's U.S. phase III HANDEL study with investigational compound oral alitretinoin meets study endpoints]]> http://www.basilea.com/News-and-Media/Basileas-U-S-phase-III-HANDEL-study-with-investigational-compound-oral-alitretinoin-meets-study-endpoints/427 Mon, 12 Mar 2012 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basileas-U-S-phase-III-HANDEL-study-with-investigational-compound-oral-alitretinoin-meets-study-endpoints/427 <![CDATA[Basilea reports 2011 financials with better than expected operating results]]> http://www.basilea.com/News-and-Media/Basilea-reports-2011-financials-with-better-than-expected-operating-results/426 Thu, 09 Feb 2012 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basilea-reports-2011-financials-with-better-than-expected-operating-results/426 <![CDATA[Basilea to file application for marketing authorization of ceftobiprole for the treatment of pneumonia]]> http://www.basilea.com/News-and-Media/Basilea-to-file-application-for-marketing-authorization-of-ceftobiprole-for-the-treatment-of-pneumonia/423 Thu, 05 Jan 2012 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basilea-to-file-application-for-marketing-authorization-of-ceftobiprole-for-the-treatment-of-pneumonia/423 <![CDATA[Basilea appoints Chief Financial Officer]]> http://www.basilea.com/News-and-Media/Basilea-appoints-Chief-Financial-Officer/420 Wed, 07 Dec 2011 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basilea-appoints-Chief-Financial-Officer/420 <![CDATA[Extraordinary general meeting of shareholders of Basilea Pharmaceutica Ltd.]]> http://www.basilea.com/News-and-Media/Extraordinary-general-meeting-of-shareholders-of-Basilea-Pharmaceutica-Ltd-/418 Tue, 29 Nov 2011 18:30:00 +0100 http://www.basilea.com/News-and-Media/Extraordinary-general-meeting-of-shareholders-of-Basilea-Pharmaceutica-Ltd-/418 <![CDATA[Basilea announces date and agenda of extraordinary general meeting]]> http://www.basilea.com/News-and-Media/Basilea-announces-date-and-agenda-of-extraordinary-general-meeting/416 Fri, 28 Oct 2011 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-announces-date-and-agenda-of-extraordinary-general-meeting/416 <![CDATA[Basilea announces conclusion of BAL30072 phase I multiple ascending dose study]]> http://www.basilea.com/News-and-Media/Basilea-announces-conclusion-of-BAL30072-phase-I-multiple-ascending-dose-study/413 Tue, 25 Oct 2011 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-announces-conclusion-of-BAL30072-phase-I-multiple-ascending-dose-study/413 <![CDATA[Basilea receives request for extraordinary shareholders meeting to elect additional members to the board of directors]]> http://www.basilea.com/News-and-Media/Basilea-receives-request-for-extraordinary-shareholders-meeting-to-elect-additional-members-to-the-board-of-directors/411 Thu, 06 Oct 2011 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-receives-request-for-extraordinary-shareholders-meeting-to-elect-additional-members-to-the-board-of-directors/411